Alzheimer's Disease Biomarker Profile in Cerebrospinal Fluid of Individuals with Immune-Mediated Encephalitis

FERNANDEZ SUAREZ, MARCOS; SURACE, EZEQUIEL I.; RIUDAVETS, MIGUEL; NOGUES, MARTIN; VAZQUEZ, SILVIA; SEVLEVER, GUSTAVO; ALLEGRI, RICARDO F.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY.

WILEY-BLACKWELL PUBLISHING, INC

Año: 2016 vol. 64 p. 29 - 31

0002-8614

Amyloid-beta plaques are one of the neuropathologicalhallmarks of Alzheimer?s disease (AD), butdespite increasing knowledge, the precise role of this peptideand its precursor protein, amyloid precursor protein(APP), remains elusive.1 During the last decade, muchattention has been paid to the quantification of ADbiomarkers in cerebrospinal fluid (CSF), resulting in theirinclusion in the 2011 National Institute on Aging?Alzheimer?sAssociation AD criteria